Smoking cessation services in primary care, pharmacies, local authorities and workplaces, particularly for manual working groups, pregnant women and hard to reach communities

This guidance has been partially updated by PH48 Smoking cessation - acute, maternity and mental health services Some of the recommendations in this guidance have been replaced by: Tobacco: harm-reduction approaches to smoking (NICE public health guidance 45) Smoking cessation in secondary care: acute, maternity and mental health services (NICE public health guidance 48). For recommendations on the use of smokeless tobacco see Smokeless tobacco cessation - South Asian communities (NICE public health guidance 39). See the guidance for more information. This guidance is for NHS and other professionals who have a direct or indirect responsibility for services that help people to stop smoking. It may also be of interest to members of the public who wish to quit. The guidance advises the NHS, local authorities and their partners on the range of services that should be available for everyone who smokes or uses tobacco in any form. In particular, this includes pregnant women, those aged under 20, manual workers and people who are on a low income or income support. It also gives advice on the training and education that managers and staff in stop smoking services need. Recommended treatments that have been proven to be effective, either separately or combined, include: brief interventions by a GP and other practitioners working in a GP practice or the community (including advice, self-help materials and referral for more intensive support) individual behavioural counselling group behaviour therapy pharmacotherapies (for example, nicotine replacement therapy (NRT),varenicline or bupropion) self-help materials telephone counselling and quitlines mass-media campaigns to get the stop-smoking message across – using a combination of, for example, TV, radio and newspaper advertising. This guidance supersedes TA39 Smoking cessation - bupropion and nicotine replacement therapy. It crossreferences and is consistent with PH1 Brief interventions and referral for smoking cessation in primary care and other settings, PH5 Workplace health promotion: how to help employees to stop smoking and TA123 Varenicline for smoking cessation.